Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people with HIV with hyporesponse after primary vaccination.

Marlou J JongkeesDaryl GeersKathryn S HensleyWesley HuismanCorine H GeurtsvanKesselSusanne BogersLennert GommersGrigorios PapageorgiouSimon P JochemsJan G den HollanderEmile F SchippersHeidi S M AmmerlaanWouter F W BiermanMarc van der ValkMarvin A H BerrevoetsRobert SoetekouwNienke LangebeekAnke H W BrunsEliane M S LeytenKim C E SigaloffMarit G A van VonderenCorine E DelsingJudith BrangerPeter D KatsikisYvonne M MuellerRory D de VriesBart J A RijndersKees BrinkmanCasper RokxAnna H E Roukens

Published in: The Journal of infectious diseases (2022)

An additional mRNA-1273 vaccination induced a robust serological response in 97% of PWH with a hyporesponse after primary vaccination.

Keyphrases

sars cov
antiretroviral therapy
human immunodeficiency virus
hepatitis c virus
hiv positive
binding protein
high glucose